Question

Respond to the following questions in your discussion forum post:

Describe one of the new superbugs such as CRE, MRSA, Clostridium difficile, etc. that are causing havoc in our health care facilities.

What strategies are being employed to combat these new threats to our public health?

Note: Initial answers to the discussion question have to be substantive and in the range of 250 to 400 words. At least 2 references used should be listed. Initial discussion question responses are due by 11:55 p.m. (EST) on Thursday of this week.

Answer 1

Methicillin-Resistant Staphylococcus Aureus (MRSA)   is one of the superbugs infection that is resistant to the antibiotic methicillin. There are many staph aureus bacteria that infecting people and needs the unique way of treatment and protection. This needs a immediate medical attention.According to 2013 CDC report, more than 2 million people are ill due to antibiotic resistance infection and 23,000 die from infection every year. The overuse or the incorrect use of antibiotic leads to resistance.

Patients with the weakened immune system are more prone to MRSA infection. MRSA is spread through physical contacts or infected body fluids. The MRSA infected skin wound has red swollen painful pus.

The Strategies:

• Superbugs threats not only the public but also the clinicians, scientists, public health officials and others.
• MRSA is not only found in hospitals but also widely present in community settings.
• National Strategy for Combating Antibiotic-Resistant Bacteria (CARB) and President's Council of Advisors on science and technology address antibiotic resistance as the public health threat.
• Healthcare providers are trying to detect the pathogens within hours rather waiting for long hours for culture.
• Researchers are enforcing to develop vaccines for MRSA.
• Antibiotic Resistance Leadership Goals are in the clinical trials of introducing new antibiotics for the antibiotic-resistant organisms.
• Efforts were taken in the healthcare settings to minimize the use of antibiotics with purpose.
• Organizations should have evidence-based guidelines for the prevention of MRSA infection.
• Organizations should focus on the implementation of preventive measures and reduction of HAI.
• Develop Risk assessment and screening of MRSA in the hospital surveillance for prevention and control of spread.
• Health practitioners, government leaders, drug industry, and the general public should work together to solve the problem.